Regulatory Science and Policy Educational Activities
The AACR and the U.S. Food and Drug Administration have a long history of collaboration on educational initiatives. Through these efforts, the AACR and FDA work together to bring the latest in cancer science to reviewers at the agency and the latest in drug development and regulatory science to members of the AACR. Learn more about our initiatives through the links below.
This fellowship is designed to promote scientific progress through exchange of scientific knowledge in oncology education, collaborative learning, and research. Through targeted educational activities and interactions with experts from the AACR and the FDA Oncology Center of Excellence, FDA-AACR Oncology Educational Fellows will increase their familiarity and experience with oncology drug development and the regulatory review process.
Project Livin’ Label is an educational initiative in collaboration with the FDA that aims to foster broad understanding of the associated oncology product label and increase awareness of recent oncology drug FDA approvals in the cancer community through on-demand videos.
This series brings scientific leaders to the FDA campus to present cutting-edge advances in cancer biology to FDA scientific review staff and to foster the development of relationships between FDA reviewers and external scientific experts.